- This event has passed.
Biotech Showcase
January 7 - January 9
Event Navigation
Biotech Showcase™
January 7–9, 2019 in San Francisco, CA
Ready to propel your company to the next level? Biotech Showcase is the dynamic investor conference where life science dealmakers converge to drive the future of drug development. Since its inception in 2009, the appeal of Biotech Showcase to innovative companies and investors has continued to climb with now over 3,600 people in attendance! This event is considered a critical benchmark for strategic development as you have the opportunity to meet with hundreds of investors, including institutional, private equity, angel and venture investors in search of innovative life sciences and biotech companies.
REGISTRATION:
REGISTER NOW! – Use code Labiotech1 to save USD200. Book your hotel now, as the city sells out quickly.
BIOTECH SHOWCASE OFFERS:
• 3 full days to network and engage with biotech investors, leaders, and pharma executives
• 400+ of the most innovative companies will present developments in a variety of therapeutic areas
• Sessions and workshops featuring the most prominent industry thought leaders and experts
• Identity “best-fit” investors, companies, and partners in one-to-one meetings facilitated by partneringONE
WHO WILL YOU MEET?
• 3,600+ attendees
• 2,200+ companies
• 900+ investors
• 400+ public and private company presentations
• 7,500+ one-to-one meetings
• 50+ countries
SESSION TOPICS INCLUDE:
• Investing in next gen immunotherapies
• NASH MOAs
• The booming biotech ecosystem
• Reexamining Alzheimer’s
• The financing frenzy
• At the intersection of policy and sentiment: Its impact on the industry
• Early seed alternative financing
SPEAKERS INCLUDE:
• Kristin Carey – Managing Director, Cain Brothers
• Gabriel Cavazos – Managing Director, Leerink Partners LLC
• Robert Habib – CEO, MiNA Therapeutics
• Michelle Keefe – President, Commercial Solutions, Syneos Health
• Philippe Lopes-Fernandes – Senior VP, Global Head of Business Development and Alliance Management, Merck
• Casey Lynch – CEO, Cortexyme
• Bibhash Mukhopadhyay – Principal, New Enterprise Associates (NEA)
• Marian T. Nakada – VP Venture Investments, Johnson & Johnson Innovation, JJDC
• Dennis Purcell – Founder and Senior Advisor, Aisling Capital
• Camille Samuels – Partner, Venrock
• Ted Tenthoff – Analyst, Piper Jaffray & Co.
• Alex Zisson – Managing Director, H.I.G. Biohealth Partners
DOWNLOAD THE EVENT BROCHURE:
● 2019 program
● 2018 presenting company profiles
